Evidence map›Paper›PMID 36875795›Full record

ArticleBiochemistry and biophysics reports2023

New perspective for an old drug: Can naloxone be considered an antioxidant agent?

Rossana Migheli, Giada Lostia, Grazia Galleri, Gaia Rocchitta, Pier Andrea Serra, Ilaria Campesi, Valentina Bassareo, Elio Acquas, Alessandra T Peana

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Probing the Therapeutic Efficacy ofBioinformatics and biology insights · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rossana MigheliDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
Giada LostiaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
Grazia GalleriDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
Gaia RocchittaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
Pier Andrea SerraDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
Ilaria CampesiDepartment of Biomedical Sciences, University of Sassari, 07100, Sassari, Italy.
Valentina BassareoDepartment of Biomedical Sciences and Center of Excellence for the Study of Neurobiology of Addiction, University of Cagliari, 09042, Monserrato, Cagliari, Italy.
Elio AcquasDepartment of Life and Environmental Sciences and Center of Excellence for the Study of Neurobiology of Addiction, University of Cagliari, 09042, Monserrato, Cagliari, Italy.
Alessandra T PeanaDepartment of Medicine, Surgery and Pharmacy, University of Sassari, 07100, Sassari, Italy.
University of Sassari · ITUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Experimental evidence indicates that Naloxone (NLX) holds antioxidant properties. The present study aims at verifying the hypothesis that NLX could prevent oxidative stress induced by hydrogen peroxide (H Methods: To investigate the antioxidant effect of NLX, initially, we performed electrochemical experiments by means of platinum-based sensors in a cell-free system. Subsequently, NLX was tested in PC12 cells on H Results: This study reveals that NLX counteracts intracellular ROS production, reduces H Conclusion: Overall, these findings provide a starting point for studying further the protective effects of NLX on oxidative stress.

Indexed as

Hydrogen peroxideNaloxoneOxidative stressPC12cellsPlatinum-based sensors

Identifiers

PMID36875795
PMCPMC9975616
OpenAlexW4321381997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.